Free-to-attend conference & exhibition for
diabetes healthcare professionals
Join thousands of diabetes healthcare professionals at DPC2018
Diabetes Professional Care (DPC) is a unique, free-to-attend, CPD-accredited event for healthcare professionals (HCPs) involved in the prevention, treatment and management of diabetes, and its related conditions.
Launched in 2015, DPC meets a real and increasing need for accessible education among HCPs by arming them with the skills and knowledge to provide better care for their patients.
DPC2017 attracted a record attendance of 3,235 visitors – and DPC2018 promises to be even bigger and better! So, if you’re a professional responsible for delivering diabetes care pathways at any level, it is the one event you can’t afford to miss.
“I think it’s paramount for everyone who’s involved in diabetes, and has a passion and care for diabetes, to be here.”
Chris Chapman, Group Managing Director, GlucoRx
Why attend DPC2018?
Hear what our participants have to say about DPC
DPC2017 brought together more than 3,200 visitors, speakers and exhibitors at a unique event aimed at improving the lives of people with diabetes.
“Definitely come. It’s a free event. There’s so much in the way of friendly people who are here to offer their support, their guidance and their knowledge. What more can we ask for?”
Stephanie Peckham, Nurse, Nuffield Health Chichester
“What is special about DPC is that it brings together so many disparate groups under one roof, once a year. I think it’s amazing.”
Keith Vaz MP, Chair, All Party Parliamentary Group for Diabetes
"DPC is a fantastic platform, representing endless opportunities to engage with key healthcare professionals who are changing diabetes care in the UK."
Sanjay Gohil, UK/Ire Sales Director, Glooko
"Come along. There’s a lot of education, a lot of policy, a lot of interaction, a lot of learning from each other."
Dr Partha Kar, Associate National Clinical Director for Diabetes, NHS England
Countdown to DPC2018
DPC2018 News & Blog
Visitors to DPC2018 will get an exclusive first look in the UK at outcomes data from a large study on the impact of SGLT2 inhibitors on type 2 diabetes patients with high CV risk. Cardiovascular outcomes with SGLT2 inhibitors in…
Continuous glucose monitoring (CGM) is transforming self management and care for people with type 1 diabetes. Not only does CGM technology eliminate the need for painful fingerstick blood glucose testing*, but it can also improve HbA1c levels and exposure to…
An international expert professor, who will speak at the DPC2018 conference, says diabetes services for older people are “too fragmented” leaving them “vulnerable to poor health” in the later stages of their lives. Professor Alan Sinclair, from the Foundation for Diabetes…